Intravenous immunoglobulin for Alzheimer's disease

To assess the clinical efficacy and safety of IVIG for treatment of AD at any clinical stage.

This is a protocol.

Health topics:

Mental health > Dementia & cognition > Interventions aimed at causes of the disease

Neurology > Dementia & cognition > Treatment aimed at causes of the disease

Published:

4 August 2015

Authors:

He D, Liu C, Chu L, Hao Z, Chen N, Liu F, Fang X, Tian T

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
He D, Liu C, Chu L, Hao Z, Chen N, Liu F, Fang X, Tian T. Intravenous immunoglobulin for Alzheimer's disease. Cochrane Database of Systematic Reviews 2015, Issue 8. Art. No.: CD011827. DOI: 10.1002/14651858.CD011827